TrialAnnals of surgical oncology2022
Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma.
Ryusei Matsuyama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it